C07K 7/52
With only normal peptide links in the ring
Official title: with only normal peptide links in the ring
C07K7/52 (With only normal peptide links in the ring) appears on 49 US grants and 73 published applications in this corpus.
Search patents in C07K- Granted patents
- 49
- Published applications
- 73
- Assignees
- 50
- Inventors
- 185
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 2 | 3 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 3 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 2 |
| 2013 | 2 | 4 |
| 2014 | 2 | 3 |
| 2015 | 3 | 0 |
| 2016 | 2 | 7 |
| 2017 | 4 | 6 |
| 2018 | 3 | 2 |
| 2019 | 1 | 5 |
| 2020 | 2 | 2 |
| 2021 | 5 | 7 |
| 2022 | 2 | 8 |
| 2023 | 4 | 3 |
| 2024 | 4 | 8 |
| 2025 | 4 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptides as inhibitors of fibrotic matrix accumulation28 Oct 2025US 12,454,551 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Treatment of non-alcoholic fatty liver disease26 Aug 2025US 12,398,180 B2Nuritas Limited
- Cyclic peptidomimetic for the treatment of neurological disorders4 Mar 2025US 12,240,920 B2Brown University
- Macrocyclic compounds and methods of use thereof7 Jan 2025US 12,187,816 B2Genentech, Inc.
- Polypeptide conjugates for intracellular delivery of stapled peptides15 Oct 2024US 12,115,224 B2Ohio State Innovation Foundation
- Anticancer agent26 Feb 2026US 2026/0053886 A1The Trustees of Princeton University
- Macrocyclic immunomodulators7 Aug 2025US 2025/0250299 A1Bristol-Myers Squibb Company
- Macrocyclic compounds and methods of use thereof24 Apr 2025US 2025/0129125 A1Genentech, Inc.
- Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making23 Jan 2025US 2025/0026790 A1California Institute of Technology
- Polypeptide and its use as a CCK receptor agonist/antagonist19 Dec 2024US 2024/0415918 A1Centre for Regenerative Medicine & Health, Hong Kong Institute of Science & Innovation, Chinese
Most cited
By later US patents
- Compstatin analogs for treatment of neuropathic pain36US 9,421,240 B2Apellis Pharmaceuticals, Inc. · 2016
- Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making14US 11,007,245 B2California Institute of Technology · 2021
- Cyclopeptides of the formula I14US 5,693,612 AMerck Patent GmbH · 1997
- Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making14US 9,913,875 B2California Institute of Technology · 2018
- Immunomodulators9US 9,861,680 B2Bristol-Myers Squibb Company · 2018